Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy (vol 11, pg 175, 2024)

被引：0
作者：
Yang, H.
Cong, T.
Luo, Y.
Yang, C.
Ren, J.
Li, X.
机构：
来源：
JOURNAL OF HEPATOCELLULAR CARCINOMA | 2024年 / 11卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.2147/JHC.S467902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：563 / 563
页数：1
相关论文
共 50 条
[21]   Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives [J].
Girardi, Daniel M. ;
Pacifico, Jana Priscila M. ;
Guedes de Amorim, Fernanda P. L. ;
dos Santos Fernandes, Gustavo ;
Teixeira, Marcela C. ;
Pereira, Allan A. L. .
PHARMACEUTICALS, 2021, 14 (01) :1-21
[22]   CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma [J].
Palaz, Fahreddin ;
Ozsoz, Mehmet ;
Zarrinpar, Ali ;
Sahin, Ilyas .
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 :975-995
[23]   Efficacy and Prognostic Factors of Sorafenib Targeted Therapy for Advanced Hepatocellular Carcinoma [J].
Sun Long ;
Yang Shiwei ;
Fang Qing ;
Liu Ping ;
Zhang Rongjie ;
Hu Chunfang ;
Hao Yingxue .
LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (01) :120-125
[24]   Prognostic Prediction and Risk Stratification of Transarterial Chemoembolization Combined with Targeted Therapy and Immunotherapy for Unresectable Hepatocellular Carcinoma: A Dual-Center Study [J].
Kang, Wendi ;
Zhao, Huafei ;
Lian, Qicai ;
Li, Hang ;
Zhou, Xuan ;
Li, Hao ;
Weng, Siyuan ;
Yan, Zhentao ;
Yang, Zhengqiang .
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 :2169-2179
[25]   Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis [J].
Yang, Teng-Kai ;
Yu, Ya-Fang ;
Tsai, Chiao-Ling ;
Li, Hsing-Ju ;
Yang, Po-Sheng ;
Huang, Kai-Wen ;
Cheng, Jason Chia-Hsien .
BMC CANCER, 2022, 22 (01)
[26]   Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis [J].
Teng-Kai Yang ;
Ya-Fang Yu ;
Chiao-Ling Tsai ;
Hsing-Ju Li ;
Po-Sheng Yang ;
Kai-Wen Huang ;
Jason Chia-Hsien Cheng .
BMC Cancer, 22
[27]   Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy [J].
Farasati Far, Bahareh ;
Rabie, Dorsa ;
Hemati, Parisa ;
Fooladpanjeh, Parastoo ;
Faal Hamedanchi, Neda ;
Broomand Lomer, Nima ;
Karimi Rouzbahani, Arian ;
Naimi-Jamal, Mohammad Reza .
LIVERS, 2023, 3 (01) :121-160
[28]   Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy [J].
Nishikawa, Hiroki ;
Nishijima, Norihiro ;
Enomoto, Hirayuki ;
Sakamoto, Azusa ;
Nasu, Akihiro ;
Komekado, Hideyuki ;
Nishimura, Takashi ;
Kita, Ryuichi ;
Kimura, Toru ;
Iijima, Hiroko ;
Nishiguchi, Shuhei ;
Osaki, Yukio .
ONCOLOGY LETTERS, 2017, 14 (02) :1637-1647
[29]   Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma [J].
Tazi, El Mehdi ;
Essadi, Ismail ;
M'rabti, Hind ;
Touyar, Anass ;
Errihani, Hassan P. R. .
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2011, 3 (04) :167-175
[30]   Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma [J].
Bin X. ;
Luo Z. ;
Wang J. ;
Zhou S. .
Computational and Mathematical Methods in Medicine, 2023, 2023
12345